HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alfredo Fusco Selected Research

Neoplastic Cell Transformation

1/2019HMGA and Cancer: A Review on Patent Literatures.
5/2014HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
1/2010HMGA1 protein expression in familial breast carcinoma patients.
9/2009Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein.
12/2007Roles of HMGA proteins in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alfredo Fusco Research Topics

Disease

131Neoplasms (Cancer)
06/2022 - 02/2002
43Carcinogenesis
02/2021 - 02/2002
37Carcinoma (Carcinomatosis)
06/2022 - 01/2002
35Thyroid Neoplasms (Thyroid Cancer)
06/2022 - 09/2002
17Pituitary Neoplasms (Pituitary Adenoma)
03/2020 - 05/2002
17Adenoma (Adenomas)
01/2018 - 01/2002
16Papillary Thyroid Cancer
06/2019 - 12/2002
14Anaplastic Thyroid Carcinoma
01/2020 - 06/2002
13Breast Neoplasms (Breast Cancer)
06/2019 - 10/2002
9Papillary Carcinoma
06/2022 - 06/2002
6Neoplasm Metastasis (Metastasis)
01/2021 - 09/2011
6Adenocarcinoma
11/2014 - 01/2003
5Neoplastic Cell Transformation
01/2019 - 12/2007
4B-Cell Lymphoma (Lymphoma, B Cell)
02/2022 - 05/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
02/2012 - 09/2004
3Genomic Instability
02/2021 - 01/2016
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 06/2004
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2020 - 03/2005
3Seminoma
04/2020 - 03/2005
3Glioma (Gliomas)
02/2017 - 07/2004
3Colonic Neoplasms (Colon Cancer)
01/2015 - 10/2002
3Insulin Resistance
09/2012 - 07/2005
3Prolactinoma (Prolactinomas)
09/2010 - 12/2005
3Multiple Endocrine Neoplasia Type 2b (MEN 3)
06/2006 - 06/2002
2Brain Neoplasms (Brain Tumor)
01/2019 - 10/2016
2Liposarcoma
12/2018 - 11/2003
2Lung Neoplasms (Lung Cancer)
05/2018 - 11/2015
2Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018 - 11/2008
2Cholangiocarcinoma
01/2017 - 01/2003
2Ovarian Epithelial Carcinoma
08/2015 - 07/2003
2Glucose Intolerance
09/2012 - 05/2009
2Goiter
09/2012 - 10/2003

Drug/Important Bio-Agent (IBA)

86Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2002
30HMGA ProteinsIBA
02/2022 - 01/2003
30MicroRNAs (MicroRNA)IBA
04/2020 - 09/2007
17Messenger RNA (mRNA)IBA
04/2020 - 04/2003
10ProlactinIBA
01/2017 - 05/2002
10Phosphotransferases (Kinase)IBA
04/2015 - 02/2002
8DNA (Deoxyribonucleic Acid)IBA
02/2021 - 04/2005
8Cadherins (E-Cadherin)IBA
01/2020 - 06/2005
8Growth Hormone (Somatotropin)IBA
01/2018 - 05/2002
7Long Noncoding RNAIBA
03/2020 - 01/2018
7Transcription Factors (Transcription Factor)IBA
01/2019 - 05/2003
7Oncogene Proteins (Oncogene Protein)IBA
05/2018 - 06/2002
7Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2009 - 02/2002
6HMGA2 ProteinIBA
12/2018 - 11/2003
6Protein Tyrosine PhosphatasesIBA
05/2018 - 07/2004
6Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 10/2003
5Biological ProductsIBA
02/2021 - 07/2003
5RNA (Ribonucleic Acid)IBA
01/2020 - 06/2002
5Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
01/2016 - 02/2003
5Cyclin-Dependent Kinase Inhibitor p27IBA
09/2007 - 10/2002
4RacivirIBA
06/2022 - 06/2007
4LigandsIBA
01/2017 - 08/2004
4Tyrosine (L-Tyrosine)FDA Link
01/2016 - 11/2004
41-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2016 - 07/2004
4Insulin ReceptorIBA
09/2012 - 07/2005
4Insulin (Novolin)FDA Link
09/2012 - 07/2005
3Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2020 - 08/2004
3Competitive Endogenous RNAIBA
11/2019 - 01/2015
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2015
3Pharmaceutical PreparationsIBA
01/2019 - 11/2007
3OsteopontinIBA
01/2019 - 01/2015
3Cyclin EIBA
01/2019 - 02/2012
3Histones (Histone)IBA
01/2018 - 01/2014
3ChromatinIBA
11/2017 - 09/2004
3Protein Isoforms (Isoforms)IBA
02/2017 - 01/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2011
3Nuclear Proteins (Protein, Nuclear)IBA
12/2016 - 05/2006
3Cetuximab (Erbitux)FDA Link
05/2016 - 11/2014
3Polycomb-Group ProteinsIBA
09/2014 - 04/2011
3Hormones (Hormone)IBA
01/2012 - 05/2002
3dl1520 (ONYX-015)IBA
11/2007 - 06/2002
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2007 - 07/2004
3Complementary DNA (cDNA)IBA
11/2004 - 05/2002
2Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 10/2016
2Enhancer of Zeste Homolog 2 ProteinIBA
01/2020 - 04/2011
2Serine (L-Serine)FDA Link
01/2018 - 01/2011
2mycalolIBA
01/2017 - 08/2013
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017 - 12/2004
2Cyclin B1IBA
10/2016 - 01/2015
2Small Interfering RNA (siRNA)IBA
10/2016 - 01/2008
2Irinotecan (Camptosar)FDA LinkGeneric
05/2016 - 11/2015
2Progesterone Receptors (Progesterone Receptor)IBA
02/2016 - 11/2004
2Indicators and Reagents (Reagents)IBA
02/2016 - 11/2004
2Polycomb Repressive Complex 1IBA
02/2015 - 01/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2015 - 10/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014 - 10/2003
2Histone Deacetylase InhibitorsIBA
11/2014 - 06/2013
2ErbB Receptors (EGF Receptor)IBA
11/2014 - 12/2002
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2014 - 10/2002
2PhosphoproteinsIBA
09/2013 - 09/2004
2LipidsIBA
08/2013 - 07/2007
2Peptides (Polypeptides)IBA
07/2013 - 10/2012
2Estrogens (Estrogen)FDA Link
12/2012 - 11/2004
2Glucose (Dextrose)FDA LinkGeneric
09/2012 - 05/2009
2Chemokine CXCL12IBA
09/2011 - 08/2004

Therapy/Procedure

30Therapeutics
01/2019 - 10/2002
3Investigational Therapies (Experimental Therapy)
02/2022 - 06/2002
3Radiotherapy
10/2016 - 06/2002